PLEUR-EVAC AUTOTRANSFUSION SYSTEM -TENTATIVE— 510(k) K851024

Name: FDA 510(k) clearance K851024
Creator: U.S. Food and Drug Administration
Published: 1985-05-23

Substantially Equivalent

Pfizer, Inc.

FDA 510(k) clearance K851024 for PLEUR-EVAC AUTOTRANSFUSION SYSTEM -TENTATIVE, Substantially Equivalent on 1985-05-23. Applicant: Pfizer, Inc.. Device class: 2.

Clearance details

Applicant: Pfizer, Inc.
Product code: Code CAC
Device class: Class 2
Regulation: 21 CFR 868.5830
Advisory panel: Anesthesiology
Date received: 1985-03-12
Decision date: 1985-05-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ny, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CAC

view all

K241236 — XTRA Collection sets; XTRA Sequestration set X2024-08-16
K240426 — Aventus Clot Management System2024-05-14
K240584 — XTRA Autotransfusion System (with XTRA Bowl sets)2024-04-29
K231782 — FlowSaver Blood Return System (80-101)2023-07-14
K221483 — FlowSaver Blood Return System2023-02-17

More clearances from Pfizer, Inc.

view all

K181102 — ThermaCare Quick Therapy TENS2018-09-15
K991620 — VISINE FOR CONTACTS1999-09-24
K892264 — ORALCHEK SUPER-SOFT BRUSH1989-06-14
K892360 — WATER JEL STERILE GEL-SOAKED BURN DRESSING1989-06-05
K881378 — PFIZER HOSPITAL PRODUCTS GROUP ACL DRILL GUIDE1988-06-17

Adverse events under product code CAC

product code CAC

Death: 11
Malfunction: 477
Total: 488

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.